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Summary 
Natural killer (NK) cells have been shown to express a clonally distributed ability to recognize 
HLA class I alleles. The previously defined NK clones belonging to "group 1" recognize HLA- 
Cw*0401  (Cw4) and other HLA-C alleles  sharing Asn at position 77 and Lys at position 80. 
Conversely, the "group 2" NK clones recognize HLA-Cw*0302 (Cw3) and other HLA-C alleles 
characterized by Ser at position 77 and Asn at position 80. We assessed directly the involvement 
of these two residues in the capacity of NK cell clones to discriminate between the two groups 
of HLA-C alleles. To this end, Cw3 and Cw4 alleles were subjected to site-directed mutagenesis. 
Substitution of the amino acids typical of the Cw3 allele (Ser-77 and Asn-80) with those present 
in Cw4 (Ash-77 and Lys-80) resulted in a Cw3 mutant that was no longer recognized by group 
2 NK cell clones, but that was recognized by group I clones. Analysis of Cw3 or Cw4 molecules 
containing  single amino  acid substitutions  indicates  roles for Lys-80 in  recognition  mediated 
by group I clones and for Ser-77 in recognition mediated by group 2 clones. These results dem- 
onstrate that NK-mediated specific recognition of HLA-C allotypes is affected by single natural 
amino  acid substitutions  at  positions 77 and 80 of the  heavy chain. 
N 
'K cells recognize HLA class I alleles via clonally distri- 
buted surface receptors (1-6). The NK receptor/HLA 
class I molecule interaction results, in most instances, in the 
generation of a negative signal that inhibits the cytolytic ac- 
tivity of NK cells, thus preventing target cell lysis. As shown 
by the analysis of NK cell clones, a subset of NK cells speci- 
fically recognizes HLA-C molecules. In particular,  a group 
of NK clones ("group 1") recognizes Cw4 and other HLAoC 
molecules (Cw2,  CwS,  and Cw6) having  Asn at position 
77 and Lys at position 80 of the heavy chain  sequence.  A 
second group of NK clones ("group 2") recognizes Cw3 and 
related alleles (Cwl, Cw7, and CwS) sharing Set at position 
77  and Asn at position  80 (5-7).  Of note is that  residues 
77 and 80 are localized in the peptide-binding  groove and 
more precisely in the F pocket (8). Given the correlation be- 
tween NK-mediated recognition of HLA-C allotypes and the 
dimorphism defined by amino acid substitution at positions 
77 and 80, we have assessed  whether  directed mutagenesis 
at these two sites affects NK-mediated recognition of HLA-C. 
We find that  single amino  acid substitutions  are sufficient 
to modify recognition of HLA-C alleles by group 1 or group 
2  NK clones. 
Materials and Methods 
Cloning  of CD3-16 §  § Lymphocytes.  PBL were isolated on 
Ficoll-Hypaque gradients and then incubated for 30 rain at 4~ 
with a mixture of anti-CD3 (OKT3; Ortho Pharmaceuticals, Rar- 
itan, NJ), anti-CD4 (HP2.6), and anti-CD8 (]39.4) mAbs followed 
by treatment with rabbit complement for 1 h at 37~  as described 
previously (9). Viable cells were isolated and cloned under limiting 
dilution conditions in the presence of irradiated feeder cells, 0.5% 
(vol/vol) PHA (Gibco Ltd., Paisley, Scotland), and exogenous IL-2 
(rlL-2; Cetus Corp., Emeryville, CA), as previously described for 
both T and NK cell cloning  (9-11). 
Site-directed Mutagenesis.  Site-directed  mutagenesis  was  per- 
formed using two-step PCK as described by Ho et al. (12). This 
605  J. Exp. Med. ￿9  The Rockefeller University Press ￿9 0022-1007/95/08/0605/05 $2.00 
Volume 182  August 1995  605-609 Table  1.  Primers Used for Site-directed Mutagenesis of HLA-Cw3 or HLA-Cw4 Alleles 
HLA-C cDNA 
Primer  Sequence  nucleotide  number 
Universal UP*  CGCCAGGGTTTTCCCAGTCACGAC  (M13mp19)* 
Universal DOWN  CTCCGCAGGGTAGAAGC  692-708 
A  CGCAGTTTCCGCAGGTTCA  299-317 
B  GTGAACCTGCGGAAACTG  298-316 
C  CGCAGTTTCCGCAGGCTCA  299-317 
D  GTGAGCCTGCGGAAACTG  298-316 
E  CGCAGGTTCCGCAGGTTCA  299-317 
F  GTGAACCTGCGGAACCTG  298-316 
* Each set of primers was used in a 30 cycles PCR (30 s at 94~  30 s at 55~  30 s at 72~  followed by a final elongation of 7 min at 72~ 
* The universal primer UP has been designed on the sequence of M13mp19 vector and therefore does not correspond to any cDNA nucleotide number. 
method requires  two specific mutagenic primers (forward and back- 
ward) and two universal primers flanking the region to be mu- 
tated. Briefly, in separate PCR tubes, two fragments of the target 
gene were amplified. Each PCR used one universal primer at one 
end of the gene sequence and one mutagenic internal primer that 
contained the mismatched base at the site to be mutated. As tem- 
plate, M13mp19-HLA-C*0302  (Cw3) and M13mp19-HLA-C*0401 
(Cw4) were used.  Amplification fragments obtained in the first 
step were gel purified and used in the second PCR with universal 
primers. The oligonucleotide sequences  of the primers are shown 
in Table 1. Primers A and B were designed to generate the Cw3 
double  mutant  (Cw3-DM),  in  which  residues  77 and 80  were 
changed to Asn and Lys by inducing nucleotide mutations at posi- 
tions  302  and  312,  respectively  (indicating  cDNA  nucleotide 
number). To generate single mutated Cw3 or Cw4 molecules (Cw3- 
SMS0 or Cw4-SM77) carrying either Set-77 and Lys-80 or Ash-77 
and Ash-80 (Cw3-SM77 or Cw4-SM80), the set of primers C and 
D or the primer combination E and F were used, respectively. Each 
set of primers was used for 30 cycles of PCR (30 s at 94~  30 s 
at 55~  30 s at 72~  with a final elongation of 7 min at 72~ 
using a thermocycler (Perkin-Elmer Corp.,  Norwalk,  CT).  Pro- 
ducts obtained from the second PCR were digested with the re- 
striction enzymes Sail and PstI, and inserted into M13mp19-HLA- 
Cw*0302 or M13mp19-HLA-Cw*0401, which had been cleaved 
with the same enzymes. Sequences  of the 600-bp fragments in- 
serted in M13mp19 were determined to verify the fidelity of the 
mutations. 
HLA-C Constructs and Transfections.  1.1-kb  SalI-HindlIl frag- 
ments (blunted at HindlII site) containing HLA-C-coding regions 
were  isolated  from  M13mp19  constructs  and  inserted  into  the 
pRSV.5 neo (13) expression vector previously digested with SalI- 
BamHI (blunted at BamHI site). The same approach was used to 
obtain pRSV.5-HLA-B*4601 from M13mp18-HLA-B*4601.  Either 
the HLA class I constructs or the pRSV.5 neo vector alone (used 
as negative control) were transfected by electroporation (250  V, 
500 #F) into the HLA-A, -B, and -C class I null cell line LCL 721.221 
(14) (indicated as 221, for simplicity) using a gene pulser (Bio-Rad 
Laboratories, Hercules, CA). After electroporation, cells were seeded 
in 75-cm  2 flasks and selected,  after 96-h culture, in medium con- 
taining 0.6 mg/ml G418. Surface expression of HLA-C and HLA-B 
molecules was analyzed by indirect immunofluorescence using the 
HLA-C-specific mAb  F4/326  (15) or  the  HBl15  mAb  (anti- 
HLA-B) (16). Cells expressing class I molecules were isolated by 
immunomagnetic purification using anti-HLA-C or -B mAbs and 
magnetic microspheres coated with anti-mouse Ig (Dynal, Oslo, 
Norway). Enriched cell populations were cloned by limiting dilu- 
tion and selected clones were used as target cells in cytolytic assays. 
Cytolytic Assays.  The cytolytic activity of cloned NK cells was 
assessed in  a 4-h SlCr release  assay in which  effector cells were 
tested against K562 target cells, the murine P815 cell line (either 
transfected with the HLA-Cw3 gene or untransfected) (3), or the 
Cw4 §  CIR  human  cell  line  (17).  NK  cell  clones  of defined 
HLA-C allele  specificity,  indicated as group 1 (Cw4 specific) or 
group 2 (Cw3 specific), were tested against the HLA class 1-nega- 
tive cell line 221; either untransfected, transfected with the pRSV.5 
neo expression vector alone or transfected with one of the following 
native or mutated HLA class I alleles: HLA-Cw3, HLA-Cw4, HLA- 
B46, HLA-Cw3-DM, HLA-Cw3-SM77, HLA-Cw3-SM80, HLA- 
Cw4-SM77,  and HLA-Cw4-SM80. 
Results and Discussion 
221 Cells Transfected with HLA-Cw3 or HLA-Cw4 Are Pro- 
tected  from Lysis by I~'fferent Groups of  NK Clones.  The human 
221 cell line,  which lacks surface expression of HLA-A,  -B, 
and -C molecules (14), was transfected with cDNA coding 
for different HLA class I heavy chains.  221 cells transfected 
with HLA-C alleles were analyzed for surface expression of 
HLA-C molecules using F4/326, an mAb specific for an epi- 
tope shared by all HLA-C allotypes (15).  As shown in Fig. 
1, 221 cells transfected with either Cw3 (Fig.  1 C) or Cw4 
(Fig.  1 D) cDNA expressed high levels of HLA-C.  On the 
contrary, no HLA-C expression was detected in untransfected 
221 cells (Fig.  1 A) or 221 cells transfected with the RSV.5 
neo  vector  (Fig.  1 B). 
Previous studies have indicated that target cells expressing 
the Cw3 allele are protected from lysis by NK dories belonging 
to group 2,  whereas expression of Cw4 confers protection 
from group  1 NK clones (3,  5-7).  In the present study, we 
examined whether the HLA class I-negative, NK-sensitive, 
221  cell line  similarly acquired  resistance  to lysis upon ex- 
pression  of appropriate  HLA-C alleles.  As shown  in  Table 
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Figure  1.  Surface  expression of native or 
mutant  HLA-Cw3  or  HLA-Cw4  alleles 
transfected in the HLA class I-negative 221 
cell line. The HLA class I-negative 221 cell 
line was transfected with HLA-Cw3 (C), 
HLA-Cw4 (D), and with mutants obtained 
by site-directed mutagenesis at positions 77 
and/or 80 (E-/), as indicated in the text. A 
natural chimeric molecule (HLA-B46)  con- 
taining in a backbone of  HLA-B62  molecules, 
the relevant 77 and 80 amino acid positions 
of  Cw3 has also  been transfected ~J). (A) Un- 
transfected 221 cells; (B) 221 cells transfected 
with the expression vector RSV.5 neo alone. 
Cells were stained with  the F4/326 mAb 
specific for HLA-C molecules or HBl15, 
specific for HLA-B molecules, followed by 
a fluorescein-conjugated  goat anti-mouse sec- 
ond reagent, a.u., arbitrary units. 
2,  while  221  cells  transfected with  the pRSV.5  neo vector 
alone were lysed by representative clones belonging to either 
group  1 or group 2  NK clones,  Cw3-transfected 221 cells 
(221/Cw3) were resistant to lysis by group 2 clones and sus- 
ceptible to group 1 NK clones. Conversely, Cw4-transfected 
221 cells were lysed by group 2 but not group 1 NK clones. 
Protective Effect of HLA-Cw3 Molecules Mutated at Positions 
77 and~or 80.  To investigate the role of residues 77 and 80 
in the differential protective effect exerted by HLA-C allo- 
types we generated,  using site-directed mutagenesis,  a mu- 
tant Cw3 in which positions 77 and 80 were substituted with 
the amino acids present in the Cw4 heavy chain. The resulting 
mutant, termed Cw3-DM, had Ash (instead of Set) at posi- 
tion 77 and Lys (instead of Ash) at position 80. 221 cells trans- 
fected with  Cw3-DM (221/CW3-DM)  were analyzed for 
the surface expression of the mutated HLA-C allele. As shown 
Table  2.  Protective  Effect of Native or Mutagenized HLA-Cw3 and HLA-Cw4 Molecules  from Group 1 or Group 2 NK Clone- 
mediated L ysis 
221  221  221  221  221 
221  221  Cw3  Cw3  Cw3  Cw4  Cw4  221 
221"  Cw3  Cw4  DM  SM-77  SM-80  SM-77  SM-80  B46 
Aa positions  77/80  -/-  Ser/Asn  Asn/Lys  Asn/Lys  Asn/Asn  Ser/Lys  Ser/Lys  Asn/Asn  Set/Ash 
NK clones 
Group  1# 
Group 2 
2F3  95~  100  5  14  100  2  0  100  83 
1F23  100  46  5  3  51  4  5  72  94 
PIC12  64  62  5  2  52  4  2  71  31 
AM72  95  2  46  70  31  7  9  70  8 
G15  100  8  65  89  74  21  2  95  14 
B5  85  1  38  58  44  6  8  61  7 
* Target cells were represented by the HLA class I-negative human 221 cell line transfected with either the RSV.5 neo-expressing vector alone 
simply indicated as 221 or with the indicated HLA-C or FILA-B molecules. 
Alloreactive clones belonging to the two groups of specificities were obtained as described in a previous report (9). 
s Results are expressed as percent of slCr release at an E/T ratio of 10:1. 
607  Biassoni  et al.  Brief  Definitive Report in Fig.  1 E,  the HLA-C expression of 221/Cw3-DM  was 
comparable to that of 221/Cw3 or 221/Cw4 cells.  We ana- 
lyzed the ability of Cw3-DM molecules to protect 221 cells 
from lysis by group 1 or group 2 clones. As shown in Table 
2, 221/Cw3-DM cells were resistant  to lysis by group 1 clones, 
but were lysed by group 2 clones. Evident is that 221/Cw3- 
DM cells display the same pattern of susceptibility and resis- 
tance  to lysis  as 221/Cw4 cells. 
To investigate further  whether one of the two positions 
play a predominant  role in  the protective effect, we made 
Cw3 mutants in which either residue 77 or 80 was mutated 
to the residue found at  the homologous position in Cw4: 
mutant Cw3-SM77 has Ash at position 77 (substituted from 
Ser) and mutant Cw3-SMd0 has Lys at position 80 (substituted 
from Ash). 
After transfection, both Cw3-SM77 and Cw3-SM80 were 
expressed at the surface of 221 cells at levels comparable to 
those seen for the Cw3 and Cw4 transfectants (Fig. 1, F and 
G). As shown in Table 2, the 221/Cw3-SM77 cells were lysed 
by both group  1 and group 2 NK clones. In contrast,  the 
221/Cw3-SMdO cells were resistant to both group I and group 
2 NK clones. It thus appears that  the presence of a Ser-77 
is crucial for protection  from lysis by group 2 NK clones. 
These results also show that the introduction of Lys at posi- 
tion 80 confers to Cw3 molecules the capacity to protect target 
cells from lysis by group 1 NK clones. Moreover, Cw3-SMd0 
maintained the ability to protect 221 target cells from group 
2  NK clones. 
Protective Effect of HLA-Cw4 Molecules Mutated at Position 
77 or 80.  Since single amino acid substitutions are sufficient 
to modify the protective effect of Cw3 molecules, we exam- 
ined whether mutant Cw4 molecules, possessing the amino 
acids typical of the Cw3 allele at positions 77 or 80 (Ser and 
Asn, respectively), acquired a Cw3-1ike protective effect. Two 
Cw4 mutants, having a substitution at either position 77 or 
80, were made and transfected in 221 cells. As shown in Fig. 
1, H  and I), 221 cells expressing the made Cw4-SM77 mu- 
tant or the Cw4-SMd0 mutant  expressed levels of HLA-C 
comparable to the Cw3 or Cw4 transfectants.  In cytolytic 
assays, the 221/Cw4-SM80 cells were lysed by both group 
1 and group 2 NK clones (Table 2), whereas the 221/Cw4- 
SM77 cells resisted to lysis by both groups of NK clones (Table 
2). These results confirm that Lys-80 plays a crucial role in 
the protective effect from group 1 clones, and they also indi- 
cate that Set-77 is important for conferring protection from 
group 2 clones. 
221 Cells Transfected  with HLA-B46.  We further analyzed 
the role of the 77 and 80 amino acid positions in an unusual 
HLA-B  allele  (HLA-B*4601).  This  allele  has  a  chimeric 
primary structure that is identical to that of HLA-B62, ex- 
cept in residues 66-77 of the od helix,  where it is identical 
to Cw3 (18). Thus, at positions 77 and 80, B46 has the same 
residues as Cw3. HLA-B46 molecules were brightly expressed 
on 221  transfectants  (Fig.  1J).  In addition,  221/B46 cells 
were found to be resistant to group 2 but not to group 1 NK 
cell clones, thus mimicking the protective effect of Cw3 mol- 
ecules (Table 2). 
Concluding Remarks.  The data presented here demonstrate 
that single amino acid substitutions at position 77 or 80 in 
Cw3 and Cw4 molecules are sufficient to alter the protec- 
tion of target cells from lysis by the group 1 and 2 NK cell 
clones. Lys 80 is essential for protection from group 1 clones 
and Ser  77 is essential for protection from group 2 clones. 
In addition,  when Cw3 mutant molecules having the Asn 
77 and Lys 80 residues present  in Cw4 alleles were made, 
they were found to have lost the protective effect typical of 
Cw3 and instead acquired that typical of Cw4. Our results 
are consistent with the finding by Storkus et al. that amino 
acid substitution at position 74, in the od helix of HLA-A2, 
modified the capacity of this molecule to protect target cells 
from lysis by polyclonal NK cells obtained from peripheral 
blood (19). 
Noteworthy is that residues 77 and 80 are in the peptide- 
binding groove and, more precisely, contribute to the forma- 
tion of the F pocket. According to Zemmour and Parham, 
both amino acids have potential contact with a bound pep- 
tide (20).  Thus, one may visualize a role for bound peptide 
in the protective effect. In this context, NK cells may recog- 
nize directly the bound peptide or, alternatively, they could 
sense changes in the conformation of class I MHC molecules 
caused by peptide binding. 
Of relevance  is  the  protective  capability of an  unusual 
HLA-B allele,  HLA-B*4601.  In this molecule,  the peptide 
binding groove appears to be largely composed of amino acids 
belonging to the HLA-B allele. Transfectants  of 221 cells with 
B46 allele were found to be resistant to group 2 but not to 
group 1 NK clones, thus behaving like 221/Cw3-transfected 
cells.  Since one may speculate that,  in HLA-B46,  peptide 
binding  is influenced primarily  by HLA-B-encoded struc- 
tures, we suggest that the type of bound peptide is not cru- 
cial  for the NK-mediated  recognition. 
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